T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression

作者：Solmaz Yazdani, Christina Seitz, Can Cui, Anikó Lovik, Lu Pan, Fredrik Piehl, Yudi Pawitan, Ulf Kläppe, Rayomand Press, Kristin Samuelsson, Li Yin, Trung Nghia Vu, Anne-Laure Joly, Lisa S. Westerberg, Björn Evertsson, Caroline Ingre, John Andersson, Fang Fang · 发表于：Nature Communications · 年份：2022 · DOI：10.1038/s41467-022-34526-9 · 被引用次数：117 · 研究领域：Amyotrophic Lateral Sclerosis Research、Neuroinflammation and Neurodegeneration Mechanisms

Abstract Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease, involving neuroinflammation and T cell infiltration in the central nervous system. However, the contribution of T cell responses to the pathology of the disease is not fully understood. Here we show, by flow cytometric analysis of blood and cerebrospinal fluid (CSF) samples of a cohort of 89 newly diagnosed ALS patients in Stockholm, Sweden, that T cell phenotypes at the time of diagnosis are good predictors of disease outcome. High frequency of CD4 + FOXP3 − effector T cells in blood and CSF is associated with poor survival, whereas high frequency of activated regulatory T (Treg) cells and high ratio between activated and resting Treg cells in blood are associated with better survival. Besides survival, phenotypic profiling of T cells could also predict disease progression rate. Single cell transcriptomics analysis of CSF samples shows clonally expanded CD4 + and CD8 + T cells in CSF, with characteristic gene expression patterns. In summary, T cell responses associate with and likely contribute to disease progression in ALS, supporting modulation of adaptive immunity as a viable therapeutic option.